Pro- and Antiinflammatory Cytokine Signaling: Reciprocal Antagonism Regulates Interferon-gamma Production by Human Natural Killer Cells

Immunity

Volumn 24, Issue 5, 2006, Pages 575-590

  Yu, Jianhua ^a   Wei, Min ^a   Becknell, Brian ^a   Trotta, Rossana ^a   Liu, Shujun ^a   Boyd, Zachary ^a   Jaung, Michael S ^a   Blaser, Bradley W ^a   Sun, Jin ^a   Benson Jr , Don M ^a   Mao, Hsiaoyin ^a   Yokohama, Akihiko ^a   Bhatt, Darshna ^a   Shen, Lei ^a   Davuluri, Ramana ^a   Weinstein, Michael ^a   Marcucci, Guido ^a,b   Caligiuri, Michael A ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MONOKINE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SHWARTZMAN PHENOMENON; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 33646563695     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.03.016     Document Type: Article

References (90)

1. Afkarian M., Sedy J.R., Yang J., Jacobson N.G., Cereb N., Yang S.Y., Murphy T.L., and Murphy K.M. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3 (2002) 549-557
2. Akahoshi M., Obara K., Hirota T., Matsuda A., Hasegawa K., Takahashi N., Shimizu M., Nakashima K., Cheng L., Doi S., et al. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum. Genet. 117 (2005) 16-26
3. Akira S. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12 (2000) 59-63
4. Antonelli M. Sepsis and septic shock: pro-inflammatory or anti-inflammatory state?. J. Chemother. 11 (1999) 536-540
5. Avni O., Lee D., Macian F., Szabo S.J., Glimcher L.H., and Rao A. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3 (2002) 643-651
6. Becknell B., Trotta R., Yu J., Ding W., Mao H.C., Hughes T., Marburger T., and Caligiuri M.A. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. J. Immunol. Methods 296 (2005) 115-123
7. Bellone G., Aste-Amezaga M., Trinchieri G., and Rodeck U. Regulation of NK cell functions by TGF-beta 1. J. Immunol. 155 (1995) 1066-1073
8. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., and Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12 (2001) 27-36
9. Bone R.C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125 (1996) 680-687
10. Born T.L., Thomassen E., Bird T.A., and Sims J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273 (1998) 29445-29450
11. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3 (2003) 521-533
12. Bright J.J., and Sriram S. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161 (1998) 1772-1777
13. Bright J.J., Kerr L.D., and Sriram S. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J. Immunol. 159 (1997) 175-183
14. Castriconi R., Cantoni C., Della Chiesa M., Vitale M., Marcenaro E., Conte R., Biassoni R., Bottino C., Moretta L., and Moretta A. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100 (2003) 4120-4125
15. Cho J.Y., Grigura V., Murphy T.L., and Murphy K. Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-gamma promoter. Int. Immunol. 15 (2003) 1149-1160
16. Chua A.O., Chizzonite R., Desai B.B., Truitt T.P., Nunes P., Minetti L.J., Warrier R.R., Presky D.H., Levine J.F., Gately M.K., et al. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153 (1994) 128-136
17. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., and Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
18. Davuluri R.V., Grosse I., and Zhang M.Q. Computational identification of promoters and first exons in the human genome. Nat. Genet. 29 (2001) 412-417
19. Dennler S., Goumans M.J., and ten Dijke P. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 71 (2002) 731-740
20. Derynck R., Zhang Y., and Feng X.H. Smads: transcriptional activators of TGF-beta responses. Cell 95 (1998) 737-740
21. Di Noto R., Pane F., Camera A., Luciano L., Barone M., Lo Pardo C., Boccuni P., Intrieri M., Izzo B., Villa M.R., et al. Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma. Leukemia 15 (2001) 1641-1649
22. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112 (1997) 321S-329S
23. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
24. Dunn G.P., Bruce A.T., Ikeda H., Old L.J., and Schreiber R.D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3 (2002) 991-998
25. Dunn G.P., Old L.J., and Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21 (2004) 137-148
26. Eriksson M., Meadows S.K., Wira C.R., and Sentman C.L. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J. Leukoc. Biol. 76 (2004) 667-675
27. Espevik T., Figari I.S., Shalaby M.R., Lackides G.A., Lewis G.D., Shepard H.M., and Palladino Jr. M.A. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166 (1987) 571-576
28. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., and Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162 (1999) 4511-4520
29. Fehniger T.A., Yu H., Cooper M.A., Suzuki K., Shah M.H., and Caligiuri M.A. Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo. J. Immunol. 164 (2000) 1643-1647
30. Gong J.H., Maki G., and Klingemann H.G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8 (1994) 652-658
31. Gorelik L., Constant S., and Flavell R.A. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195 (2002) 1499-1505
32. Gray J.D., Hirokawa M., Ohtsuka K., and Horwitz D.A. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 160 (1998) 2248-2254
33. Grignani F., Kinsella T., Mencarelli A., Valtieri M., Riganelli D., Lanfrancone L., Peschle C., Nolan G.P., and Pelicci P.G. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58 (1998) 14-19
34. Han H.S., Jun H.S., Utsugi T., and Yoon J.W. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice. J. Autoimmun. 10 (1997) 299-307
35. Hata A., Lo R.S., Wotton D., Lagna G., and Massague J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388 (1997) 82-87
36. Hayes M.P., Murphy F.J., and Burd P.R. Interferon-gamma-dependent inducible expression of the human interleukin-12 p35 gene in monocytes initiates from a TATA-containing promoter distinct from the CpG-rich promoter active in Epstein-Barr virus-transformed lymphoblastoid cells. Blood 91 (1998) 4645-4651
37. Heremans H., Dillen C., Dijkmans R., Grau G., and Billiau A. The role of cytokines in various animal models of inflammation. Lymphokine Res. 8 (1989) 329-333
38. Hill N., and Sarvetnick N. Cytokines: promoters and dampeners of autoimmunity. Curr. Opin. Immunol. 14 (2002) 791-797
39. Horwitz D.A., Gray J.D., Ohtsuka K., Hirokawa M., and Takahashi T. The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity. Immunol. Today 18 (1997) 538-542
40. Horwitz D.A., Gray J.D., and Ohtsuka K. Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect. 1 (1999) 1305-1311
41. Ishida Y., Kondo T., Takayasu T., Iwakura Y., and Mukaida N. The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J. Immunol. 172 (2004) 1848-1855
42. Jouanguy E., Doffinger R., Dupuis S., Pallier A., Altare F., and Casanova J.L. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11 (1999) 346-351
43. Laouar Y., Sutterwala F.S., Gorelik L., and Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 6 (2005) 600-607
44. Lee J.C., Lee K.M., Kim D.W., and Heo D.S. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J. Immunol. 172 (2004) 7335-7340
45. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16 (1998) 137-161
46. Lin J.T., Martin S.L., Xia L., and Gorham J.D. TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. J. Immunol. 174 (2005) 5950-5958
47. Liu X., Sun Y., Weinberg R.A., and Lodish H.F. Ski/Sno and TGF-beta signaling. Cytokine Growth Factor Rev. 12 (2001) 1-8
48. Lugo-Villarino G., Maldonado-Lopez R., Possemato R., Penaranda C., and Glimcher L.H. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 100 (2003) 7749-7754
49. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., and Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183 (1996) 147-157
50. McInnes I.B., and Gracie J.A. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr. Opin. Pharmacol. 4 (2004) 392-397
51. Messi M., Giacchetto I., Nagata K., Lanzavecchia A., Natoli G., and Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat. Immunol. 4 (2003) 78-86
52. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., Kung A.L., Cereb N., Yao T.P., Yang S.Y., and Reiner S.L. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292 (2001) 1907-1910
53. Mullen A.C., Hutchins A.S., Villarino A.V., Lee H.W., High F.A., Cereb N., Yang S.Y., Hua X., and Reiner S.L. Cell cycle controlling the silencing and functioning of mammalian activators. Curr. Biol. 11 (2001) 1695-1699
54. Mullen A.C., Hutchins A.S., High F.A., Lee H.W., Sykes K.J., Chodosh L.A., and Reiner S.L. Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat. Immunol. 3 (2002) 652-658
55. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19 (2001) 423-474
56. Neurath M.F., Weigmann B., Finotto S., Glickman J., Nieuwenhuis E., Iijima H., Mizoguchi A., Mizoguchi E., Mudter J., Galle P.R., et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195 (2002) 1129-1143
57. Ohteki T. Critical role for IL-15 in innate immunity. Curr. Mol. Med. 2 (2002) 371-380
58. Pardoux C., Ma X., Gobert S., Pellegrini S., Mayeux P., Gay F., Trinchieri G., and Chouaib S. Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling. Blood 93 (1999) 1448-1455
59. Pearce E.L., Mullen A.C., Martins G.A., Krawczyk C.M., Hutchins A.S., Zediak V.P., Banica M., DiCioccio C.B., Gross D.A., Mao C.A., et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302 (2003) 1041-1043
60. Presky D.H., Yang H., Minetti L.J., Chua A.O., Nabavi N., Wu C.Y., Gately M.K., and Gubler U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93 (1996) 14002-14007
61. Prunier C., Pessah M., Ferrand N., Seo S.R., Howe P., and Atfi A. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J. Biol. Chem. 278 (2003) 26249-26257
62. Reed S.G. TGF-beta in infections and infectious diseases. Microbes Infect. 1 (1999) 1313-1325
63. Ross M.E., and Caligiuri M.A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89 (1997) 910-918
64. Sareneva T., Julkunen I., and Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165 (2000) 1933-1938
65. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2004) 163-189
66. Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., and Schreiber R.D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410 (2001) 1107-1111
67. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
68. Strengell M., Sareneva T., Foster D., Julkunen I., and Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol. 169 (2002) 3600-3605
69. Sudarshan C., Galon J., Zhou Y., and O'Shea J.J. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs. J. Immunol. 162 (1999) 2974-2981
70. Sullivan B.M., Juedes A., Szabo S.J., von Herrath M., and Glimcher L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100 (2003) 15818-15823
71. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., and Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000) 655-669
72. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., and Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002) 338-342
73. Takeda M., Mizuide M., Oka M., Watabe T., Inoue H., Suzuki H., Fujita T., Imamura T., Miyazono K., and Miyazawa K. Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. Mol. Biol. Cell 15 (2004) 963-972
74. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., Gapin L., and Glimcher L.H. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20 (2004) 477-494
75. Trinchieri G. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin. Immunol. 7 (1995) 83-88
76. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
77. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90 (1993) 3725-3729
78. Trotta R., Parihar R., Yu J., Becknell B., Allard II J., Wen J., Ding W., Mao H., Tridandapani S., Carson W.E., and Caligiuri M.A. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood 105 (2005) 3011-3018
79. Ulloa L., Doody J., and Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397 (1999) 710-713
80. Visconti R., Gadina M., Chiariello M., Chen E.H., Stancato L.F., Gutkind J.S., and O'Shea J.J. Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity. Blood 96 (2000) 1844-1852
81. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., and O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202 (2004) 139-156
82. Wotton D., and Massague J. Smad transcriptional corepressors in TGF beta family signaling. Curr. Top. Microbiol. Immunol. 254 (2001) 145-164
83. Wrana J.L., Attisano L., Wieser R., Ventura F., and Massague J. Mechanism of activation of the TGF-beta receptor. Nature 370 (1994) 341-347
84. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., and Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18 (1999) 1280-1291
85. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., Akira S., and Nakanishi K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161 (1998) 3400-3407
86. Yoshimura A., Mori H., Ohishi M., Aki D., and Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr. Opin. Immunol. 15 (2003) 704-708
87. Yu L., Hebert M.C., and Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21 (2002) 3749-3759
88. Zhang S., and Kaplan M.H. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J. Immunol. 165 (2000) 1374-1380
89. Zhang Y., Feng X., We R., and Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383 (1996) 168-172
90. Zhang Y., Feng X.H., and Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394 (1998) 909-913